Acquired MET D1228V mutation and resistance to MET inhibition in lung cancer

Amplified and/or mutated MET can act as both a primary oncogenic driver and as a promoter of tyrosine kinase inhibitor (TKI) resistance in non-small cell lung cancer (NSCLC). However, the landscape of MET-specific targeting agents remains underdeveloped and understanding of mechanisms of resistance...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Cancer Discov
Main Authors: Bahcall, Magda, Sim, Taebo, Paweletz, Cloud P., Patel, Jyoti D., Alden, Ryan S., Kuang, Yanan, Sacher, Adrian G., Kim, Nam Doo, Lydon, Christine A., Awad, Mark M., Jaklitsch, Michael T., Sholl, Lynette M., Jänne, Pasi A., Oxnard, Geoffrey R.
Formáid: Artigo
Teanga:Inglês
Foilsithe: 2016
Ábhair:
Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5140694/
https://ncbi.nlm.nih.gov/pubmed/27694386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-16-0686
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla